STAT3 is persistently activated in a number of NSCLC cell lines [51] as well as 50% of lung adenocarcinomas, with a trend toward higher pSTAT3 expression in tumors with bronchioloalveolar carcinoma or adenocarcinoma histology [52]. This evidence concerns the gene STAT3 and adenocarcinoma.